Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carol M. Johnson"'
Autor:
Suchith Shetty, Carol M. Johnson, Abbas Ali, Anthony L. Panos, Emmanuel Akintoye, Alexandros Briasoulis, Umesh C. Sharma, Ernesto Ruiz Duque, Rupesh Kshetri, Paulino Alvarez
Publikováno v:
ASAIO Journal. 68:524-530
Data regarding the role of N-terminal Pro-B-type natriuretic peptide (NT-pro BNP) in patients with a continuous-flow left ventricular assist device (CFLVAD) is scarce. To evaluate the prognostic implications of measuring both absolute values and chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9f5c3ad6caee2d9995db534a828fea
https://doi.org/10.1097/mat.0000000000001524
https://doi.org/10.1097/mat.0000000000001524
Autor:
Peter H. Tsang, David Fried, Victoria Landolfi, Ann R. Falsey, Ayca Ozol-Godfrey, Dennis Morrison, John E. Ervin, Geoffrey J. Gorse, David P. Greenberg, Carol M. Johnson
Publikováno v:
Vaccine. 31:6034-6040
Background This clinical trial examined the safety and immunogenicity of annual revaccination with Fluzone ® Intradermal (Sanofi Pasteur, Swiftwater, PA) vaccine compared to a standard intramuscular (IM) split-virion trivalent influenza vaccine (Flu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362fa850a17344a0c9ca41a018565ea3
https://doi.org/10.1016/j.vaccine.2013.09.012
https://doi.org/10.1016/j.vaccine.2013.09.012
Publikováno v:
Vaccine. 31(44)
Background A candidate recombinant, live-attenuated, CYD tetravalent dengue vaccine (CYD-TDV) has recently demonstrated immunogenicity, efficacy and good tolerability. This study was performed to evaluate three CYD-TDV formulations in adults. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::026404abb5b825cb865f4069aab0f06d
https://pubmed.ncbi.nlm.nih.gov/24021313
https://pubmed.ncbi.nlm.nih.gov/24021313